ArticleScience China. Life sciences2025

Antithetical impacts of deleterious LRP1B mutations in non-squamous and squamous NSCLCs on predicting benefits from immune checkpoint inhibitor alone or with chemotherapy over chemotherapy alone: retrospective analyses of the POPLAR/OAK and CHOICE-01 trials.

Jinliang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.